• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

评估α-1-抗胰蛋白酶的S型作为中性粒细胞弹性蛋白酶的体内和体外抑制剂的作用。

Evaluation of the S-type of alpha-1-antitrypsin as an in vivo and in vitro inhibitor of neutrophil elastase.

作者信息

Ogushi F, Hubbard R C, Fells G A, Casolaro M A, Curiel D T, Brantly M L, Crystal R G

机构信息

Pulmonary Branch, National Heart, Lung and Blood Institute, Bethesda, Maryland 20892.

出版信息

Am Rev Respir Dis. 1988 Feb;137(2):364-70. doi: 10.1164/ajrccm/137.2.364.

DOI:10.1164/ajrccm/137.2.364
PMID:3257660
Abstract

S-type alpha 1-antitrypsin (alpha 1AT) is a deficiency haplotype that differs from the common normal M1 (val213) alpha 1AT haplotype by a single amino acid (glu264 to val264). To evaluate the adequacy of the antineutrophil elastase protection associated with the S homozygous state, alpha 1AT plasma and lung epithelial lining fluid (ELF) levels and antineutrophil elastase function were analyzed in 9 PISS subjects. The plasma alpha 1AT levels of SS subjects were intermediate between that of M1M1 and ZZ subjects (p less than 0.001, all comparisons) and the plasma neutrophil elastase inhibitory capacity paralleled the differences in alpha 1AT concentration (p less than 0.001, all comparisons). The association rate constant for neutrophil elastase of the purified S protein was less than that of the normal molecule (S-type, 7.1 +/- 0.1 X 10(6) M-1 s-1; M1-type, 9.6 +/- 0.2 X 10(6) M-1 s-1; p less than 0.001), but much greater than that for the Z molecule (p less than 0.001). Exposure of the purified S protein to increasing oxidant burdens resulted in a dose-dependent reduction in the ability of the molecule to inhibit neutrophil elastase in a fashion parallel to that of the M1 and Z proteins. Quantification of ELF alpha 1AT levels and antineutrophil elastase capacity demonstrated that the SS ELF parameters were, as in plasma, intermediate between M1 homozygotes and Z homozygotes. Using the association rate constant together with the quantification of ELF alpha 1AT levels, the "in vivo lung inhibition time" was estimated, yielding an assessment of the relative antineutrophil elastase screen of the PISS lower respiratory tract.(ABSTRACT TRUNCATED AT 250 WORDS)

摘要

S型α1-抗胰蛋白酶(α1AT)是一种缺陷单倍型,它与常见的正常M1(缬氨酸213)α1AT单倍型仅相差一个氨基酸(谷氨酸264变为缬氨酸264)。为评估与S纯合状态相关的抗中性粒细胞弹性蛋白酶保护作用是否充足,对9名PISS受试者的α1AT血浆和肺上皮衬液(ELF)水平以及抗中性粒细胞弹性蛋白酶功能进行了分析。SS受试者的血浆α1AT水平介于M1M1和ZZ受试者之间(p<0.001,所有比较),血浆中性粒细胞弹性蛋白酶抑制能力与α1AT浓度差异平行(p<0.001,所有比较)。纯化的S蛋白对中性粒细胞弹性蛋白酶的结合速率常数低于正常分子(S型,7.1±0.1×10⁶ M⁻¹ s⁻¹;M1型,9.6±0.2×10⁶ M⁻¹ s⁻¹;p<0.001),但远高于Z分子(p<0.001)。将纯化的S蛋白暴露于不断增加的氧化剂负荷下,该分子抑制中性粒细胞弹性蛋白酶的能力呈剂量依赖性降低,其方式与M1和Z蛋白平行。对ELF α1AT水平和抗中性粒细胞弹性蛋白酶能力的定量分析表明,SS的ELF参数与血浆一样,介于M1纯合子和Z纯合子之间。结合结合速率常数和ELF α1AT水平的定量分析,估计了“体内肺抑制时间”,从而对PISS下呼吸道的相对抗中性粒细胞弹性蛋白酶屏障进行了评估。(摘要截短于250字)

相似文献

1
Evaluation of the S-type of alpha-1-antitrypsin as an in vivo and in vitro inhibitor of neutrophil elastase.评估α-1-抗胰蛋白酶的S型作为中性粒细胞弹性蛋白酶的体内和体外抑制剂的作用。
Am Rev Respir Dis. 1988 Feb;137(2):364-70. doi: 10.1164/ajrccm/137.2.364.
2
Z-type alpha 1-antitrypsin is less competent than M1-type alpha 1-antitrypsin as an inhibitor of neutrophil elastase.作为中性粒细胞弹性蛋白酶的抑制剂,Z型α1抗胰蛋白酶的活性不如M1型α1抗胰蛋白酶。
J Clin Invest. 1987 Nov;80(5):1366-74. doi: 10.1172/JCI113214.
3
Comparison of alpha-1-antitrypsin levels and antineutrophil elastase capacity of blood and lung in a patient with the alpha-1-antitrypsin phenotype null-null before and during alpha-1-antitrypsin augmentation therapy.α-1抗胰蛋白酶增强治疗前及治疗期间一名α-1抗胰蛋白酶表型为无效-无效的患者血液和肺中α-1抗胰蛋白酶水平及抗中性粒细胞弹性蛋白酶能力的比较
Am Rev Respir Dis. 1987 Mar;135(3):539-43. doi: 10.1164/arrd.1987.135.3.539.
4
Risk factors for emphysema. Cigarette smoking is associated with a reduction in the association rate constant of lung alpha 1-antitrypsin for neutrophil elastase.肺气肿的危险因素。吸烟与肺α1-抗胰蛋白酶对中性粒细胞弹性蛋白酶的结合速率常数降低有关。
J Clin Invest. 1991 Mar;87(3):1060-5. doi: 10.1172/JCI115066.
5
Recombinant DNA-produced alpha 1-antitrypsin administered by aerosol augments lower respiratory tract antineutrophil elastase defenses in individuals with alpha 1-antitrypsin deficiency.通过气雾剂给药的重组DNA生产的α1-抗胰蛋白酶可增强α1-抗胰蛋白酶缺乏个体的下呼吸道抗中性粒细胞弹性蛋白酶防御能力。
J Clin Invest. 1989 Oct;84(4):1349-54. doi: 10.1172/JCI114305.
6
Oxidants spontaneously released by alveolar macrophages of cigarette smokers can inactivate the active site of alpha 1-antitrypsin, rendering it ineffective as an inhibitor of neutrophil elastase.吸烟者肺泡巨噬细胞自发释放的氧化剂可使α1-抗胰蛋白酶的活性位点失活,使其作为中性粒细胞弹性蛋白酶抑制剂失效。
J Clin Invest. 1987 Nov;80(5):1289-95. doi: 10.1172/JCI113204.
7
Characterization of the sequence of the normal alpha-1-antitrypsin M3 allele and function of the M3 protein.正常α-1-抗胰蛋白酶M3等位基因序列的特征及M3蛋白的功能
Am J Respir Cell Mol Biol. 1989 Dec;1(6):471-7. doi: 10.1165/ajrcmb/1.6.471.
8
Neutrophil accumulation in the lung in alpha 1-antitrypsin deficiency. Spontaneous release of leukotriene B4 by alveolar macrophages.α1-抗胰蛋白酶缺乏症患者肺部的中性粒细胞聚集。肺泡巨噬细胞自发释放白三烯B4。
J Clin Invest. 1991 Sep;88(3):891-7. doi: 10.1172/JCI115391.
9
Biochemical efficacy and safety of monthly augmentation therapy for alpha 1-antitrypsin deficiency.α1-抗胰蛋白酶缺乏症每月增强疗法的生化疗效与安全性
JAMA. 1988 Sep 2;260(9):1259-64.
10
Characterization of the gene and protein of the alpha 1-antitrypsin "deficiency" allele Mprocida.α1 -抗胰蛋白酶“缺陷”等位基因Mprocida的基因与蛋白质特性分析
J Biol Chem. 1988 Oct 25;263(30):15528-34.

引用本文的文献

1
Risk of lung disease in the PI*SS genotype of alpha-1 antitrypsin: an EARCO research project.PI*SS 基因型的α-1 抗胰蛋白酶缺乏症与肺部疾病风险:EARCO 研究项目。
Respir Res. 2024 Jun 26;25(1):260. doi: 10.1186/s12931-024-02879-y.
2
Clarifying the Risk of Lung Disease in SZ Alpha-1 Antitrypsin Deficiency.明确 SZ Alpha-1 抗胰蛋白酶缺乏症的肺病风险。
Am J Respir Crit Care Med. 2020 Jul 1;202(1):73-82. doi: 10.1164/rccm.202002-0262OC.
3
Intrapleural Gene Therapy for Alpha-1 Antitrypsin Deficiency-Related Lung Disease.用于α-1抗胰蛋白酶缺乏相关肺部疾病的胸膜内基因治疗。
Chronic Obstr Pulm Dis. 2018 Aug 17;5(4):244-257. doi: 10.15326/jcopdf.5.4.2017.0160.
4
Alpha-1 antitrypsin Pi*SZ genotype: estimated prevalence and number of SZ subjects worldwide.α-1抗胰蛋白酶Pi*SZ基因型:全球SZ受试者的估计患病率和数量。
Int J Chron Obstruct Pulmon Dis. 2017 Jun 8;12:1683-1694. doi: 10.2147/COPD.S137852. eCollection 2017.
5
Gene Therapy for Alpha-1 Antitrypsin Deficiency Lung Disease.α-1抗胰蛋白酶缺乏性肺病的基因治疗
Ann Am Thorac Soc. 2016 Aug;13 Suppl 4(Suppl 4):S352-69. doi: 10.1513/AnnalsATS.201506-344KV.
6
Deficient and Null Variants of SERPINA1 Are Proteotoxic in a Caenorhabditis elegans Model of α1-Antitrypsin Deficiency.在α1-抗胰蛋白酶缺乏的秀丽隐杆线虫模型中,SERPINA1的缺陷型和无效型变体具有蛋白毒性。
PLoS One. 2015 Oct 29;10(10):e0141542. doi: 10.1371/journal.pone.0141542. eCollection 2015.
7
α-1-antitrypsin variants and the proteinase/antiproteinase imbalance in chronic obstructive pulmonary disease.α-1-抗胰蛋白酶变体与慢性阻塞性肺疾病中的蛋白酶/抗蛋白酶失衡
Am J Physiol Lung Cell Mol Physiol. 2015 Jan 15;308(2):L179-90. doi: 10.1152/ajplung.00179.2014.
8
Sustained transgene expression despite T lymphocyte responses in a clinical trial of rAAV1-AAT gene therapy.在一项rAAV1 - AAT基因治疗的临床试验中,尽管存在T淋巴细胞反应,但转基因仍持续表达。
Proc Natl Acad Sci U S A. 2009 Sep 22;106(38):16363-8. doi: 10.1073/pnas.0904514106. Epub 2009 Aug 12.
9
Alpha1-antitrypsin inhibits the activity of the matriptase catalytic domain in vitro.α1-抗胰蛋白酶在体外可抑制胃蛋白酶原激活酶催化结构域的活性。
Am J Respir Cell Mol Biol. 2008 Dec;39(6):631-7. doi: 10.1165/rcmb.2008-0015RC. Epub 2008 Aug 21.
10
Molecular multitasking in the airspace: alpha1-antitrypsin takes on thrombin and plasmin.空域中的分子多任务处理:α1-抗胰蛋白酶对抗凝血酶和纤溶酶。
Am J Respir Cell Mol Biol. 2007 Aug;37(2):130-4. doi: 10.1165/rcmb.2007-0163TR. Epub 2007 May 31.